NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
05/08/2026
Voltar para busca
Dado oficial do USPTO
DCODE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
50
Atualização mais recente
05/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
06/12/2018
Data de registro
07/04/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/08/2026
Última transação
05/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
24
Localização do titular
Virum, DK
Examinador
FALK, JONATHAN ROBERT
Localização atual
Historical data usage
Titulares e representantes
Titulares
I. A. (pessoa física)
I. A. (pessoa física)
Representantes
Julie A. Greenberg Fishman Stewart PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in diagnosticsindustry and scienceother than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagentsmonoclonal antibodiesreagentsdiagnostic agentscontrol reagentsDNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapycancer vaccinesborrelia vaccinesTB-vaccinesHIV-vaccinesCMV-vaccines and other vaccinesfor analysis for research purposes of T-cell lymphomaT-cell infiltration of solid tumors and tissuefor analysis for research purposes of infectious diseasesautoimmunity and for use in connection with toxicological studies and research in relation to transplantationimmune monitoringvaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes
Classe 5
Preparations for pharmaceutical purposes for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccinesimmunotherapeutics and cellular therapiesincluding cancer vaccines and immunotherapeuticsborrelia vaccinesTB-vaccinesHIV-vaccines and CMV-vaccinesT-cell therapiesfor use in connection with cancer therapy and other medical therapiesfor analysis and treatment of T-cell lymphomaT-cell infiltration of solid tumors and tissuefor infectious diseasesfor use in connection with medical procedures and diagnosistransplantationimmune monitoringvaccines and T-cell monitoring
Publicações
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
05/08/2026
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
05/08/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/07/2026
ES75
TEAS SECTION 71 & 15 RECEIVED
08/04/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/11/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/04/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
14/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/04/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/04/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
21/01/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/07/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/08/2020
FIMP
FINAL DISPOSITION PROCESSED
14/08/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/01/2020
PUBO
PUBLISHED FOR OPPOSITION
21/01/2020
GPNX
NOTIFICATION PROCESSED BY IB
17/01/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/12/2019
ALIE
ASSIGNED TO LIE
11/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/11/2019
RFNP
REFUSAL PROCESSED BY IB
22/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/06/2019
RFRR
REFUSAL PROCESSED BY MPU
05/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/05/2019
CNRT
NON-FINAL ACTION WRITTEN
10/05/2019
MAFR
APPLICATION FILING RECEIPT MAILED
10/05/2019
DOCK
ASSIGNED TO EXAMINER
06/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/05/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/05/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DCODE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.